Screener
Vor Biopharma VOR Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: Vor Biopharma’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 8:31 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-220689
| (in thousands, except share and per share amounts) | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total assets | $506,746 | $464,126 |
| Liabilities and stockholders’ deficit | ||
| Current liabilities: | ||
| Accounts payable | $1,043 | $5,127 |
| Accrued liabilities | 14,727 | 19,764 |
| Operating lease liabilities | 307 | 280 |
| Total current liabilities | 16,077 | 25,171 |
| Non-current liabilities: |
Item 1. Financial Statements (Unaudited).
FAQ
- What is Vor Biopharma's accounts payable?
- Vor Biopharma (VOR) reported accounts payable of $1.04M in Q1 2026.
- How has Vor Biopharma's accounts payable changed year-over-year?
- Vor Biopharma's accounts payable decreased by 72.1% year-over-year, from $3.73M to $1.04M.
- What is the long-term trend for Vor Biopharma's accounts payable?
- Over 5 years (2020 to 2025), Vor Biopharma's accounts payable has grown at a 16.8% compound annual growth rate (CAGR), from $2.36M to $5.13M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Vor Biopharma's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude